Prime Therapeutics is pleased to present the ninth edition of the Medicaid Pharmacy Trend Report. This annual publication offers insights into the gross and net drug spend trends across Medicaid programs through the previous year.   

Using the Medicaid Fee-for-Service (FFS) space to the achieve the highest level of accuracy for trend reporting, our annual report details traditional and specialty drug spend and impact, the top classes and individual drugs driving trend, as well as a closer look at cytokines and cell adhesion molecule (CAM) antagonists as the top driver of Medicaid net spend. This expert analysis will drive important conversations and strategic opportunities for managing Medicaid pharmacy programs in the coming years.  

The Medicaid pharmacy economics section, included in every issue of the report, provides the fundamental background for new readers and those who need a refresher on the calculation of the federal rebate and the impact rebates have on the net price of drugs in the Medicaid program. 

                                                                                   Read the report